Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Cash from Financing Activities (2016 - 2025)

Tg Therapeutics has reported Cash from Financing Activities over the past 10 years, most recently at $1.1 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $1.1 million for Q4 2025, up 117.42% from a year ago — trailing twelve months through Dec 2025 was -$89.7 million (down 169.81% YoY), and the annual figure for FY2025 was -$89.7 million, down 169.81%.
  • Cash from Financing Activities for Q4 2025 was $1.1 million at Tg Therapeutics, up from -$78.2 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for TGTX hit a ceiling of $134.5 million in Q3 2024 and a floor of -$78.2 million in Q3 2025.
  • Median Cash from Financing Activities over the past 5 years was $29500.0 (2022), compared with a mean of $7.6 million.
  • Biggest five-year swings in Cash from Financing Activities: surged 34749.63% in 2023 and later plummeted 607100.0% in 2024.
  • Tg Therapeutics' Cash from Financing Activities stood at $56.0 million in 2021, then plummeted by 99.91% to $49000.0 in 2022, then plummeted by 102.04% to -$1000.0 in 2023, then plummeted by 607100.0% to -$6.1 million in 2024, then surged by 117.42% to $1.1 million in 2025.
  • The last three reported values for Cash from Financing Activities were $1.1 million (Q4 2025), -$78.2 million (Q3 2025), and -$6.4 million (Q2 2025) per Business Quant data.